Related Experiment Video
Updated: Sep 11, 2025
10:42
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
9.2K
Homeostatic remodeling platform for reprogramming Iron Intraspatial orientation to reverse liver fibrosis
Bo-Wen Duan1, Yan-Jun Liu1, He-Yuan Hong1
1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Summary
This study introduces a novel micelle platform to treat alcoholic liver fibrosis by restoring iron balance. The dual-action micelles selectively manage iron in liver cells, effectively reducing fibrosis and showing promise for other iron-related diseases.
Area of Science:
- Biomedical Engineering
- Hepatology
- Nanomedicine
Background:
- Chronic alcohol consumption disrupts liver iron homeostasis, causing iron overload and activating hepatic stellate cells, leading to alcoholic liver fibrosis.
- Existing treatments struggle to restore iron balance due to differing cellular iron needs, potentially worsening disease.
- Iron dysregulation is implicated in various fibrotic conditions beyond alcoholic liver disease.
Purpose of the Study:
- To develop a novel therapeutic platform for alcoholic liver fibrosis by precisely regulating iron distribution.
- To address the limitations of current treatments by targeting specific cellular iron requirements.
- To investigate the potential of this platform in other iron-related fibrotic diseases.
Main Methods:
- Development of a targeting-intelligent regulation platform using iron-depleting (Met/Gal) and iron-redirecting (Sor/DVA) micelles.
- Administration of dual micelles to suppress iron excretion in liver parenchymal cells and capture iron for hepatic stellate cells.
- Evaluation of iron homeostasis restoration, fibrosis alleviation, and therapeutic efficacy in iron-related conditions.
Main Results:
- Met/Gal micelles reduced iron excretion and inflammatory infiltration in liver parenchymal cells.
- Sor/DVA micelles selectively eliminated activated hepatic stellate cells via ferroptosis by redirecting iron.
- The platform successfully restored liver iron homeostasis and significantly alleviated fibrosis.
- Therapeutic potential was also observed in pulmonary fibrosis models.
Conclusions:
- The developed micelle platform offers a novel, dual-action strategy for treating alcoholic liver fibrosis by precisely managing iron dysregulation.
- This approach effectively restores iron homeostasis and alleviates liver fibrosis.
- The platform shows broad applicability for various iron imbalance-associated diseases, including pulmonary fibrosis.
